证券记录 · 已归档季度
ICLR
ICON Public Limited Company · Healthcare · Medical - Diagnostics & Research
13被追踪持有人
—Δ持有人
9.47M持有股份
$2.97B报告持仓市值
+0新建仓位
−0清仓
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 113 | +2 | 54.24M | $9.34B | +10 | −7 |
| Q1 2026 | 112 | -7 | 49.87M | $5.61B | +7 | −15 |
| Q4 2025 | 119 | -2 | 53.17M | $9.70B | +2 | −3 |
| Q3 2025 | 18 | -1 | 14.11M | $2.47B | +2 | −4 |
| Q2 2025 | 17 | +3 | 17.03M | $2.48B | +3 | — |
| Q1 2025 | 11 | -1 | 10.01M | $1.75B | +1 | −2 |
| Q4 2024 | 12 | -1 | 9.48M | $1.99B | +2 | −3 |
| Q3 2024 | 12 | -1 | 9.43M | $2.71B | +1 | −2 |
| Q2 2024 | 13 | — | 9.47M | $2.97B | — | — |
持有人 · Q2 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 2.76M | — | $865.06M | 0.2% | n/c | 1 | SEC ↗ |
| 2 | Wellington Management ✦ | 2.76M | — | $865.06M | 0.2% | n/c | 1 | SEC ↗ |
| 3 | Wellington Management ✦ | 2.76M | — | $865.06M | 0.2% | n/c | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 2.76M | — | $865.06M | 0.2% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 2.76M | — | $865.06M | 0.2% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 2.76M | — | $865.06M | 0.2% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 2.76M | — | $865.06M | 0.2% | n/c | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 2.76M | — | $865.06M | 0.2% | n/c | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 2.76M | — | $865.06M | 0.2% | n/c | 1 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 2.62M | — | $821.00M | 0.1% | n/c | 1 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 2.62M | — | $821.00M | 0.1% | n/c | 1 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 1.36M | — | $426.38M | 0.4% | n/c | 1 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 1.36M | — | $426.38M | 0.4% | n/c | 1 | SEC ↗ |
| 14 | Norges Bank ✦ (被动) | 969.89K | — | $304.03M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Millennium Management ✦ | 865.36K | — | $271.26M | 0.2% | n/c | 1 | SEC ↗ |
| 16 | Point72 Asset Management ✦ | 447.33K | — | $140.23M | 0.5% | n/c | 1 | SEC ↗ |
| 17 | Renaissance Technologies ✦ | 226.00K | — | $70.84M | 0.1% | n/c | 1 | SEC ↗ |
| 18 | Geode Capital Management ✦ (被动) | 82.71K | — | $25.93M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | D. E. Shaw & Co. ✦ | 79.74K | — | $25.00M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | D. E. Shaw & Co. ✦ | 79.74K | — | $25.00M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Arrowstreet Capital ✦ | 40.93K | — | $12.83M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Adage Capital Partners ✦ | 11.00K | — | $3.45M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Fisher Asset Management ✦ | 5.42K | — | $1.70M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 1.75K | — | $547,945 | 0.0% | n/c | 1 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 1.75K | — | $547,945 | 0.0% | n/c | 1 | SEC ↗ |
| 26 | AQR Capital Management ✦ | 1.75K | — | $547,945 | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 414 持有人, 78.10M 股份, $8.66B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 11
O'Neill Julie
Director · 105 股 · $17,196
Aug 11
Murphy Ronan Martin
Director · 67 股 · $11,089
Aug 11
Murray Ciaran
Director · 280 股 · $45,562
Aug 11
Murray Ciaran
Director · 305 股 · $49,950
Aug 11
Murray Ciaran
Director · 1.88K 股 · $309,204
Aug 11
Murray Ciaran
Director · 212 股 · $35,088
Aug 11
O'Neill Julie
Director · 95 股 · $15,458
Aug 11
O'Neill Julie
Director · 642 股 · $105,590
Aug 11
O'Neill Julie
Director · 73 股 · $12,082
Aug 11
Whitaker Anne Clem
Director · 88 股 · $14,319
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 13
SC 13G/A — Invesco Ltd.
Aug 06
SC 13G/A — FMR LLC
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2024 ·
方法论 ·
通过API获取此数据